Company & Sponsor Intelligence

Jiangsu Province Nanjing Brain Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting2

Completed0

Countries1

Therapeutic footprint

depressionparkinsons

Indexed studies

NCT07480317TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease
parkinsons · ChinaNA

NCT06270433Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder
depression · ChinaNA

NCT0732312140 Hz Flickering for Insomnia in Parkinson's Disease
parkinsons · ChinaNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →